Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

A Survey of Quality Attributes of Virus Spike Preparations Used in Clearance Studies

George Miesegaes, Scott Lute, Jessica Dement-Brown, Simran Kaushal, Daniel Strauss, Dayue Chen and Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology September 2012, 66 (5) 420-433; DOI: https://doi.org/10.5731/pdajpst.2012.00879
George Miesegaes
1Office of Biotechnology Products, CDER/FDA, 10903 New Hampshire Ave. Silver Spring, MD 20903 and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: george.miesegaes@fda.hhs.gov
Scott Lute
1Office of Biotechnology Products, CDER/FDA, 10903 New Hampshire Ave. Silver Spring, MD 20903 and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Dement-Brown
1Office of Biotechnology Products, CDER/FDA, 10903 New Hampshire Ave. Silver Spring, MD 20903 and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simran Kaushal
1Office of Biotechnology Products, CDER/FDA, 10903 New Hampshire Ave. Silver Spring, MD 20903 and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Strauss
2Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dayue Chen
2Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Brorson
1Office of Biotechnology Products, CDER/FDA, 10903 New Hampshire Ave. Silver Spring, MD 20903 and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 66 no. 5 420-433
DOI 
https://doi.org/10.5731/pdajpst.2012.00879
PubMed 
23035026

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online October 3, 2012.

Copyright & Usage 
© PDA, Inc. 2012

Author Information

  1. George Miesegaes1,*,
  2. Scott Lute1,
  3. Jessica Dement-Brown1,
  4. Simran Kaushal1,†,
  5. Daniel Strauss2,
  6. Dayue Chen2 and
  7. Kurt Brorson1
  1. 1Office of Biotechnology Products, CDER/FDA, 10903 New Hampshire Ave. Silver Spring, MD 20903 and
  2. 2Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285
  1. ↵* Correspondence author: Phone: (301) 796-2095. Fax: (301) 796-9817. E-mail: george.miesegaes{at}fda.hhs.gov
View Full Text

Cited By...

  • 5 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Viral clearance by flow‐through mode ion exchange columns and membrane adsorbers
    G. R. Miesegaes, S. C. Lute, E. K. Read, K. A. Brorson
    Biotechnology Progress 2014 30 1
  • Virus removal robustness of ion exchange chromatography
    Kang Cai, Jennifer Anderson, Joshua D. Orchard, Christopher D. Afdahl, Matthew Dickson, Yuling Li
    Biologicals 2019 58
  • Choice of parvovirus model for validation studies influences the interpretation of the effectiveness of a virus filtration step
    Thomas Nowak, Birgit Popp, Nathan J. Roth
    Biologicals 2019 60
  • Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus
    David J. Roush, Adam Myrold, Michael S. Burnham, Joseph V. and, Joseph V. Hughes
    Biotechnology Progress 2015 31 1
  • Particle‐based analysis elucidates the real retention capacities of virus filters and enables optimal virus clearance study design with evaluation systems of diverse virological characteristics
    Taiki Kayukawa, Akiyo Yanagibashi, Tomoko Hongo‐Hirasaki, Koichiro Yanagida
    Biotechnology Progress 2022 38 2
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 66 (5)
PDA Journal of Pharmaceutical Science and Technology
Vol. 66, Issue 5
September/October 2012
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Survey of Quality Attributes of Virus Spike Preparations Used in Clearance Studies
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Survey of Quality Attributes of Virus Spike Preparations Used in Clearance Studies
George Miesegaes, Scott Lute, Jessica Dement-Brown, Simran Kaushal, Daniel Strauss, Dayue Chen, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology Sep 2012, 66 (5) 420-433; DOI: 10.5731/pdajpst.2012.00879

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Survey of Quality Attributes of Virus Spike Preparations Used in Clearance Studies
George Miesegaes, Scott Lute, Jessica Dement-Brown, Simran Kaushal, Daniel Strauss, Dayue Chen, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology Sep 2012, 66 (5) 420-433; DOI: 10.5731/pdajpst.2012.00879
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conflict of Interest Declaration
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies
  • Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Virus-Retentive Filtration
  • Conference Summary: Gaps, Lessons Learned, and Areas for Improvement
  • Viral Clearance Integration (Session IV): General Trends, Bracketing, QbD, Virus Preparation Quality Attributes
  • Google Scholar

More in this TOC Section

  • Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
  • Evaluation of Extreme Depyrogenation Conditions on the Surface Hydrolytic Resistance of Glass Containers for Pharmaceutical Use
  • A Holistic Approach for Filling Volume Variability Evaluation and Control with Statistical Tool
Show more Research

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire